FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999611222> ?p ?o ?g. }

• W1999611222 endingPage "8967" @default.
• W1999611222 startingPage "8960" @default.
• W1999611222 abstract "We developed carrier-free multidrug nanocrystals (MDNCs) for the combination chemotherapy with synergistic effect, improved tolerance and imaging capability for cancer treatment. Three widely used hydrophobic drugs, methotrexate (MTX), 10-hydroxycamptothecin (HCPT) and paclitaxel (PTX), were prepared into one nanorod, and then conjugated with poly(ethylene glycol) (PEG) to improve their water dispersity and bio-environmental stability. It should be noted that only trace amount of PEG was used for surface modification, which ensures a high drug loading capacity of the resulting PEGylated MDNCs. In vitro studies showed that the MDNCs revealed an obviously higher cytotoxicity than individual drugs in the same dose and suppressed drug resistance against PTX resistant MCF-7/ADR cancer cells, indicating its synergistic effect and improved tolerance. After in vivo intravenous injection, the MDNCs exhibits a synergetic in vivo therapeutic effect and possesses obviously superior antitumor effect compared to free multidrugs treatment group and individual drug treatment groups, and no statistically significant weight loss was observed. The MDNCs can also gain imaging capabilities by encapsulated with an organic dye, which render the multidrug nanorod an all-in-one processing system for cancer diagnosis and treatment." @default.
• W1999611222 created "2016-06-24" @default.
• W1999611222 creator A5008199212 @default.
• W1999611222 creator A5012118798 @default.
• W1999611222 creator A5035527858 @default.
• W1999611222 creator A5041044092 @default.
• W1999611222 creator A5044887993 @default.
• W1999611222 creator A5065964687 @default.
• W1999611222 creator A5084452813 @default.
• W1999611222 date "2013-11-01" @default.
• W1999611222 modified "2023-10-14" @default.
• W1999611222 title "Carrier-free functionalized multidrug nanorods for synergistic cancer therapy" @default.
• W1999611222 cites W1533933224 @default.
• W1999611222 cites W1963526834 @default.
• W1999611222 cites W1965004808 @default.
• W1999611222 cites W1968583232 @default.
• W1999611222 cites W1979291547 @default.
• W1999611222 cites W1986802370 @default.
• W1999611222 cites W1988897281 @default.
• W1999611222 cites W1997972415 @default.
• W1999611222 cites W1999271093 @default.
• W1999611222 cites W2000691433 @default.
• W1999611222 cites W2006628039 @default.
• W1999611222 cites W2009286988 @default.
• W1999611222 cites W2010197207 @default.
• W1999611222 cites W2013270956 @default.
• W1999611222 cites W2013471060 @default.
• W1999611222 cites W2018282398 @default.
• W1999611222 cites W2018384936 @default.
• W1999611222 cites W2019298819 @default.
• W1999611222 cites W2020798897 @default.
• W1999611222 cites W2021713080 @default.
• W1999611222 cites W2021876818 @default.
• W1999611222 cites W2026680301 @default.
• W1999611222 cites W2032621729 @default.
• W1999611222 cites W2048726865 @default.
• W1999611222 cites W2050404828 @default.
• W1999611222 cites W2054308157 @default.
• W1999611222 cites W2057256078 @default.
• W1999611222 cites W2061061337 @default.
• W1999611222 cites W2080592529 @default.
• W1999611222 cites W2085586037 @default.
• W1999611222 cites W2087852082 @default.
• W1999611222 cites W2096439168 @default.
• W1999611222 cites W2103167660 @default.
• W1999611222 cites W2104558356 @default.
• W1999611222 cites W2113604872 @default.
• W1999611222 cites W2123617256 @default.
• W1999611222 cites W2131264896 @default.
• W1999611222 cites W2138003976 @default.
• W1999611222 cites W2139549149 @default.
• W1999611222 cites W2139707477 @default.
• W1999611222 cites W2141796671 @default.
• W1999611222 cites W2148692511 @default.
• W1999611222 cites W2157614936 @default.
• W1999611222 cites W2163148038 @default.
• W1999611222 cites W2167255447 @default.
• W1999611222 cites W2405302860 @default.
• W1999611222 cites W4232371418 @default.
• W1999611222 doi "https://doi.org/10.1016/j.biomaterials.2013.07.080" @default.
• W1999611222 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23958027" @default.
• W1999611222 hasPublicationYear "2013" @default.
• W1999611222 type Work @default.
• W1999611222 sameAs 1999611222 @default.
• W1999611222 citedByCount "99" @default.
• W1999611222 countsByYear W19996112222013 @default.
• W1999611222 countsByYear W19996112222014 @default.
• W1999611222 countsByYear W19996112222015 @default.
• W1999611222 countsByYear W19996112222016 @default.
• W1999611222 countsByYear W19996112222017 @default.
• W1999611222 countsByYear W19996112222018 @default.
• W1999611222 countsByYear W19996112222019 @default.
• W1999611222 countsByYear W19996112222020 @default.
• W1999611222 countsByYear W19996112222021 @default.
• W1999611222 countsByYear W19996112222022 @default.
• W1999611222 countsByYear W19996112222023 @default.
• W1999611222 crossrefType "journal-article" @default.
• W1999611222 hasAuthorship W1999611222A5008199212 @default.
• W1999611222 hasAuthorship W1999611222A5012118798 @default.
• W1999611222 hasAuthorship W1999611222A5035527858 @default.
• W1999611222 hasAuthorship W1999611222A5041044092 @default.
• W1999611222 hasAuthorship W1999611222A5044887993 @default.
• W1999611222 hasAuthorship W1999611222A5065964687 @default.
• W1999611222 hasAuthorship W1999611222A5084452813 @default.
• W1999611222 hasConcept C10138342 @default.
• W1999611222 hasConcept C114851261 @default.
• W1999611222 hasConcept C121608353 @default.
• W1999611222 hasConcept C126201875 @default.
• W1999611222 hasConcept C126322002 @default.
• W1999611222 hasConcept C133936738 @default.
• W1999611222 hasConcept C150903083 @default.
• W1999611222 hasConcept C162324750 @default.
• W1999611222 hasConcept C171250308 @default.
• W1999611222 hasConcept C178790620 @default.
• W1999611222 hasConcept C185592680 @default.
• W1999611222 hasConcept C192562407 @default.
• W1999611222 hasConcept C207001950 @default.
• W1999611222 hasConcept C2776694085 @default.

• next